George Arzeno, M.D.
Specialist in San Juan, Puerto Rico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 69,658 in Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
George Arzeno, M.D. filed 2,143 Medicare Part D claims in 2023 as a Specialist in San Juan, Puerto Rico, prescribing 0% generic.
- 2K
- Part D claims, 2023
- 0%
- generic prescribing
- $159.88
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
George Arzeno, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
2,143 Top 15% higher than 85% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about George Arzeno, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Puerto Rico
How Specialist compares to other specialties among Puerto Rico providers
Specialist ranks #14 among Puerto Rico's specialties (1.9% of in-state providers)
Each bar is a specialty's share of the Puerto Rico provider total, by primary NUCC taxonomy. The highlighted bar is Specialist; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Specialist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
George Arzeno, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 150 AVE DE DIEGO STE 707, San Juan, PR, 00907, with a listed phone of (787) 724-6090. NPI 1730189846 was issued on 07/29/2005.
Medicare Part D records for calendar year 2023 show 2,143 prescription claims written by this provider, covering 227 Medicare beneficiaries and totaling roughly $446K in drug spend, split 62% brand-name and 0% generic by claim count.
Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1730189846 |
|---|---|
| Specialty | Specialist |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/29/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm George Arzeno, M.D.'s current license status, disciplinary history, and board certifications directly with the licensing state's medical board before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1730189846 is the unique 10-digit identifier CMS uses to link Arzeno across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for George Arzeno, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$160
Largest payer
Bausch & Lomb Americas Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
62% brand-name claims vs 0% generic, on 2,143 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,001
- Total Day Supply
- 84,871
- Brand vs Generic
- 62% brand / 0% generic
- Brand Drug Cost
- $391K
Patient Demographics
- Average Patient Age
- 77.9 years
- Avg HCC Risk Score
- 1.62
- Gender Split
- 59% female / 41% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What George Arzeno, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Lumigan
Lumigan
567 claims
- Latanoprost 212
Latanoprost
212 claims
- Dorzolamide-Timolol 156
Dorzolamide-Timolol
156 claims
- Alphagan P 105
Alphagan P
105 claims
- Dorzolamide Hcl 104
Dorzolamide Hcl
104 claims
- Restasis 98
Restasis
98 claims
- Rocklatan 68
Rocklatan
68 claims
- Timolol Maleate 63
Timolol Maleate
63 claims
| Drug | Claims |
|---|---|
| Lumigan Bimatoprost | 567 |
| Latanoprost | 212 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 156 |
| Alphagan P Brimonidine Tartrate | 105 |
| Dorzolamide Hcl | 104 |
| Restasis Cyclosporine | 98 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 68 |
| Timolol Maleate | 63 |
| Combigan Brimonidine Tartrate/Timolol | 60 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How George Arzeno, M.D. fits within the Specialist landscape nationally.
George Arzeno, M.D.'s 2,143 claims are above the specialty average of 1,474.
Nearby Specialist Providers in Puerto Rico
Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as Arzeno.
Compare Specialist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Puerto Rico medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Specialist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Puerto Rico
Frequently Asked Questions
What is George Arzeno, M.D.'s specialty? ▼
How much does George Arzeno, M.D. prescribe under Medicare Part D? ▼
Where is George Arzeno, M.D. located? ▼
What is George Arzeno, M.D.'s NPI number? ▼
Does George Arzeno, M.D. prescribe more brand-name or generic drugs? ▼
How many Specialist providers are there in the US? ▼
What drugs does George Arzeno, M.D. prescribe most often? ▼
Does George Arzeno, M.D. accept Medicare? ▼
How can I verify George Arzeno, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology